MorphoSys AG - American Depositary Shares (MOR) earnings
Quarterly and annual MOR reports and results, each read against the price at its own news timestamp. Back to the MOR overview →
3 measured MOR earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| MorphoSys AG Reports First Quarter 2024 Financial Results | Press release | -0.09% | -1.64% | |
| Invitation to MorphoSys' Full Year Results 2023 Conference Call on March 14, 2024 | Press release | +0.06% | +0.17% | |
| MorphoSys AG Reports First Nine Months and Third Quarter 2023 Financial Results | Press release | -0.46% | -4.76% |
Keep exploring
More MOR: analyst actions → · SEC filings → · MOR overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Axim Biotechnologies, Inc (AXIM) | 27 | 0.00% | 16% |
| Crescita Therapeutics Inc (CTX_TSE) | 27 | 0.00% | 22% |
| ReWalk Robotics Ltd. - Ordinary Shares (RWLK) | 27 | +0.03% | 50% |
| HYPERA SA S/ADR (HYPMY) | 26 | 0.00% | 36% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.